GLP-1 and arterial inflammation — March 2026

Just wanted to say — for anyone reading this GLP-1 and arterial thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

laura_annarbor's experience with GLP-1 and arterial resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I titrated faster. But the overall trajectory has been remarkably similar. Down 48 lbs in 13 months.

One thing I would add that laura_annarbor did not mention: the relationship with food fundamentally changed.

Saving this for reference. Quality thread.

As a healthcare provider, I want to add some clinical context to this discussion on GLP-1 and arterial inflammation March.

Building on what laura_annarbor said — the evidence base here is well-established. The key publications to reference are from the STEP program[1].

Key clinical points:

1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
2. Side effect profile is predictable and usually manageable with standard protocols
3. Monitoring should include baseline labs and follow-up at 3-month intervals
4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

Subscribing to this thread. GLP-1 and arterial is exactly what I've been researching. 🙏